| For: | Ye L, Yan K, Tian Z, Xiao ZH, Xie RY, Xie ZY, Tao L. Helicobacter pylori infection is linked to metabolic dysfunction and associated steatotic liver disease: A large cross-sectional study. World J Gastroenterol 2025; 31(13): 102563 [PMID: 40248064 DOI: 10.3748/wjg.v31.i13.102563] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v31/i13/102563.htm |
| Number | Citing Articles |
| 1 |
Olga V Smirnova, Aleksander A Sinyakov, Edward V Kasparov. <i>Helicobacter pylori</i> infection as a risk factor in the development of metabolic dysfunction-associated steatotic liver disease. World Journal of Hepatology 2025; 17(10): 110833 doi: 10.4254/wjh.v17.i10.110833
|
| 2 |
Meenakshi Kandpal, Tarun Prakash Verma, Siddharth Singh, Hamendra Parmar, Hem Chandra Jha. Metabolomic and lipidomic signatures of Helicobacter pylori infection: Unveiling biochemical pathways associated with neurodegeneration. iMetaOmics 2026; doi: 10.1002/imo2.70088
|
| 3 |
Zhimao Cai, Hualang Cai, Dan Zhou, Zhenzhou Li, Jiashuang Lin, Ye Ye, Sixia Chen, Rourou Li, Mengjia Chen, Yuan Dai, Hui Peng, Weifeng Chen. Non-linear association between cardiometabolic index and helicobacter pylori infection: a cross-sectional study. European Journal of Medical Research 2026; 31(1) doi: 10.1186/s40001-026-04171-9
|
| 4 |
Fen Wang, Shuo-Yi Yao, Noube Julie Raissa. Relationship between <i>Helicobacter pylori</i> infection and the development of metabolic dysfunction and associated steatotic liver disease. World Journal of Gastroenterology 2025; 31(33): 110176 doi: 10.3748/wjg.v31.i33.110176
|
| 5 |
Han Chen, Yan Wang, Yuting Shao, Wei Su, Shuo Li, Yun Liu, Xiaoying Zhou. Multi‐Omics Analysis Revealed Characterization of Gastric Microbiome and Metabolome in Helicobacter pylori‐Induced Progression of MASLD. Helicobacter 2025; 30(5) doi: 10.1111/hel.70069
|
